Enovis (ENOV) Non Operating Investment Income (2018 - 2022)
Enovis' (ENOV) quarterly Non Operating Investment Income came in at $30.3 million in Q4 2022, up 244.32% quarter-over-quarter from $8.8 million in Q3 2022.
Powered by 
Analysis
Enovis (ENOV) Non Operating Investment Income (2018 - 2022) Analysis & Trends
Enovis (ENOV) has reported Non Operating Investment Income for 2 consecutive years, with $30.3 million the latest figure, recorded in Q4 2022.
- On a quarterly basis, Non Operating Investment Income changed N/A year-over-year to $30.3 million in Q4 2022; TTM through Dec 2023 was $39.1 million, a 77.61% decrease from a year earlier, with the FY2022 full-year figure at $102.7 million, changed N/A from the prior year.
- Non Operating Investment Income was $30.3 million for Q4 2022 at Enovis, up from $8.8 million in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $135.5 million in Q3 2022 and troughed at -$14.7 million in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | - |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 30.30 Mn |
| Sep 30, 2022 | 8.80 Mn |
| Jul 1, 2022 | 135.50 Mn |
| Dec 31, 2018 | -28,000.00 |
| Jun 29, 2018 | 4.59 Mn |
| Mar 30, 2018 | -14.72 Mn |